John Abramson
Impact in
- Pharmacology top 10%
- Pharmaceutical industry and healthcare
Papers in ⓘ
-
- Pharmaceutical industry and healthcare 5
- Co-authors
- James M Wright (2 shared papers)H Rosenberg (1 shared paper)Marc A. Rodwin (1 shared paper)Franz Goldstein (5 shared papers)Matthew J. Budoff (1 shared paper)J. Douglas Thornton (2 shared papers)A. Abraham (1 shared paper)Tomohito Hamazaki (1 shared paper)
- Journals
- JAMA (2 papers)The Lancet (2 papers)Exceptional Children (1 paper)Journal of Clinical Gastroenterology (1 paper)BMJ (1 paper)
- Partner nations
- United StatesCanadaDenmark
In The Last Decade
John Abramson
17 papers receiving 384 citations
Peers
Comparison fields: 5 of 85
- Pharmacology 74
- Medical Terminology 2
- Economics and Econometrics 192
- Family Practice 15
- Geriatrics and Gerontology 26
Countries citing papers authored by John Abramson
This map shows the geographic impact of John Abramson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Abramson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Abramson more than expected).
Fields of papers citing papers by John Abramson
This network shows the impact of papers produced by John Abramson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Abramson. The network helps show where John Abramson may publish in the future.
Co-authors
The 17 scholars most cited alongside John Abramson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 138 | |
| 2 | Overdosed America: The Broken Promise of American Medicine | 2004 | 78 |
| 3 | 2007 | 72 | |
| 4 | 2012 | 31 | |
| 5 | 1987 | 19 | |
| 6 | Favorable effects of sulfasalazine on small bowel Crohn's disease: a long-term study. | 1987 | 15 |
| 7 | Acute and relapsing pancreatitis caused by bile pigment aggregates and diagnosed by biliary drainage. | 1980 | 14 |
| 8 | 2005 | 12 | |
| 9 | Cholesterol Lowering, Cardiovascular Diseases, and the Rosuvastatin-JUPITER Controversy | 2010 | 10 |
| 10 | 1981 | 8 | |
| 11 | 1976 | 6 | |
| 12 | 1980 | 3 | |
| 13 | Anti-inflammatory drug treatment in Crohn's disease. | 1976 | 2 |
| 14 | Statins in Persons at Low Risk of Cardiovascular Disease. | 2017 | 2 |
| 15 | 2019 | 2 | |
| 16 | 2007 | 2 | |
| 17 | 2014 | 1 | |
| 18 | 2016 | 1 | |
| 19 | 2025 | 0 |
About John Abramson
John Abramson is a scholar working on Medical Terminology, Pharmacology, Economics and Econometrics, Surgery and General Health Professions, having authored 19 papers that have together received 416 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Lipoproteins and Cardiovascular Health (6 papers), Pharmaceutical industry and healthcare (5 papers), Inflammatory Bowel Disease (3 papers), Healthcare Policy and Management (2 papers), Autoimmune and Inflammatory Disorders (2 papers), Primary Care and Health Outcomes (2 papers) and Pharmaceutical Economics and Policy (2 papers). The work is most often cited by research in Pharmacology (74 citations), Medical Terminology (2 citations), Economics and Econometrics (192 citations), Family Practice (15 citations) and Geriatrics and Gerontology (26 citations). John Abramson has collaborated with scholars based in United States, Canada and Denmark. Frequent co-authors include James M Wright, H Rosenberg, Marc A. Rodwin, Franz Goldstein, Matthew J. Budoff, J. Douglas Thornton, A. Abraham, Tomohito Hamazaki, Harumi Okuyama and Sylvie Dodin. Their work appears in journals such as JAMA, The Lancet, Exceptional Children, Journal of Clinical Gastroenterology and BMJ.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.